Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2026-01-17 @ 1:06 AM
Study NCT ID:
NCT00686920
Status:
COMPLETED
Last Update Posted:
2019-08-14
First Post:
2008-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy
Sponsor:
Bausch Health Americas, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RFHE3002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None